# Novartis Bioventures Ltd: insider transactions

SEC CIK 1297709. Roles and transactions as reported on Form 4. Latest Form 4 filed 2019-05-31.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Bicycle Therapeutics plc](/companies/bcyc.md) | 10% owner | 7 | 2019-05-28 | 2019-05-28 |
| [Altimmune, Inc.](/companies/alt.md) | 10% owner | 27 | 2017-08-21 | 2018-09-12 |

## Transactions: 34

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Conversion (C), derivative | 636,366 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Option exercise (in the money) (X), derivative | 71,450 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Conversion (C), derivative | 893,195 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Purchase (P) | 168,630 | $14.00 | $2.4m | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Conversion (C) | 636,366 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Option exercise (in the money) (X) | 71,450 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2019-05-28 | [Bicycle Therapeutics plc](/companies/bcyc.md) | Conversion (C) | 893,195 | not reported | not reported | [Form 4](/filings/0001104659-19-032920.md) |
| 2018-09-12 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 465,086 | not reported | not reported | [Form 4](/filings/0001012975-18-001065.md) |
| 2018-09-12 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 2,069,993 | not reported | not reported | [Form 4](/filings/0001012975-18-001065.md) |
| 2018-07-11 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.929 | $940.00 | $324.2k | [Form 4](/filings/0001012975-18-000911.md) |
| 2018-07-11 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 663,346 | not reported | not reported | [Form 4](/filings/0001012975-18-000911.md) |
| 2018-06-15 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 14,449 | not reported | not reported | [Form 4](/filings/0001012975-18-000853.md) |
| 2018-06-13 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-18-000851.md) |
| 2018-06-13 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 720,878 | not reported | not reported | [Form 4](/filings/0001012975-18-000851.md) |
| 2018-05-16 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-18-000444.md) |
| 2018-05-16 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 767,728 | not reported | not reported | [Form 4](/filings/0001012975-18-000444.md) |
| 2018-05-15 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 274,703 | not reported | not reported | [Form 4](/filings/0001012975-18-000444.md) |
| 2018-04-16 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-18-000356.md) |
| 2018-04-16 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 217,159 | not reported | not reported | [Form 4](/filings/0001012975-18-000356.md) |
| 2018-04-16 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 482,907 | not reported | not reported | [Form 4](/filings/0001012975-18-000356.md) |
| 2018-03-15 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-18-000292.md) |
| 2018-03-15 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 261,969 | not reported | not reported | [Form 4](/filings/0001012975-18-000292.md) |
| 2018-02-15 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 67,925 | not reported | not reported | [Form 4](/filings/0001012975-18-000201.md) |
| 2018-02-13 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-18-000201.md) |
| 2018-02-13 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 269,527 | not reported | not reported | [Form 4](/filings/0001012975-18-000201.md) |
| 2018-01-17 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-18-000085.md) |
| 2018-01-17 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 176,586 | not reported | not reported | [Form 4](/filings/0001012975-18-000085.md) |
| 2017-12-15 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 65,718 | not reported | not reported | [Form 4](/filings/0001012975-17-000932.md) |
| 2017-12-13 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-17-000932.md) |
| 2017-12-13 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 242,694 | not reported | not reported | [Form 4](/filings/0001012975-17-000932.md) |
| 2017-11-14 | [Altimmune, Inc.](/companies/alt.md) | Other (J), derivative | 344.94 | not reported | not reported | [Form 4](/filings/0001012975-17-000852.md) |
| 2017-11-14 | [Altimmune, Inc.](/companies/alt.md) | Other (J) | 182,262 | not reported | not reported | [Form 4](/filings/0001012975-17-000852.md) |
| 2017-08-21 | [Altimmune, Inc.](/companies/alt.md) | Purchase (P), derivative | 465,086 | not reported | not reported | [Form 4](/filings/0001012975-17-000650.md) |
| 2017-08-21 | [Altimmune, Inc.](/companies/alt.md) | Purchase (P), derivative | 3,104.447 | $940.00 | $2.9m | [Form 4](/filings/0001012975-17-000650.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 19:37 ET. No prices; not investment advice.